Human chorionic gonadotropin hormone (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. The HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males mostly to increase the sperm count and in young boys, due to pituitary gland disorders and other diseases, due to which the testicles of the young males does not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in the determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects.
Rising incidence of infertility are expected to drive the growth of human gonadotropin market across the globe
According to Centers of Disease Control and Prevention (CDC) in 2016, approximately 7.3 million women aged 15 - 44 have used infertility services. Moreover, 6.7% of the married women aged 15 - 44 were reported infertile. According to Azura Vascular Care, around 17% of the couples in the U.S. deal with infertility out of which 30% cases are a result of male infertility. These numbers suggests significant demand for infertility treatments, such as HCG in order for females to conceive a child. According to a statistical survey conducted by HealthGrove, pituitary gland disorders resulted into the death of around 205 people in 2015, out of which highest percentage belonged to white men. Pituitary disorders resulting into significant mortality rate are propelling the demand for human chorionic gonadotropin hormone. Additionally, various other factors such as endometriosis, hormonal imbalance, polycystic ovary syndrome, and others are expected to propel the growth of global HCG market. For instance, according to Frisco Institute of Reproductive Medicine, around 10% of women of reproductive age in the U.S. suffer from polycystic ovary syndrome. However, easy availability of alternatives to treat infertility could act as potential barriers for the market growth.
The global human chorionic gonadotropin by Coherent Market Insights is segmented on the basis of Technology, Therapeutic area, and end user.
On the basis of technology, the global human chorionic gonadotropin is segmented as:
On the basis of therapeutic area, the global human chorionic gonadotropin market is segmented as:
On the basis of end user, the global human chorionic gonadotropin market is segmented as:
North America to dominate global human chorionic gonadotropin (HCG) market, owing to rising frequency of infertility cases
On the basis of geography, the global human chorionic gonadotropin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is the highest regional contributor to the market and is expected to continue as a regional dominator over the forecast years. This primarily owes to the rising number of infertility cases as well as hormonal dysfunction among young males and females as a result of changing lifestyle. According to Mayo Clinic, around 25% of women fertility problems in the U.S. are a result of ovulation issues that are mostly caused due to dysfunction of human chorionic gonadotropin (HCG) hormone. Thus, the rapidly increasing cases of infertility are expected to surge the North America global human chorionic gonadotropin market. On the other hand, Asia Pacific is anticipated to be the fasting growing geography, owing to economic developments facilitating technological advancements in healthcare sectors as well as emerging local players in the market.
The key players operating the global human chorionic gonadotropin market include Merck & Co., Inc., EMD Sereno, Inc., Fresenius Kabi, Bristol Myers Squibb Company, Ferring BV, and Kamia Biomedical Company. Acris Antibodies developed a human chorionic gonadotropin hormone by recombinant DNA technology that helps to prevent the disintegration of the corpus luteum of the ovary thereby, maintaining levels of progesterone production for healthy pregnancy in females.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.